Total Payments
$31,265
2024 Payments
$831.17
Companies
37
Transactions
500
Medicare Patients
351
Medicare Billing
$40,410
Payment Breakdown by Category
Research$23,982 (76.7%)
Food & Beverage$7,270 (23.3%)
Education$12.16 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $23,982 | 9 | 76.7% |
| Food and Beverage | $7,270 | 490 | 23.3% |
| Education | $12.16 | 1 | 0.0% |
Payments by Type
Research
$23,982
9 transactions
General
$7,282
491 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Eli Lilly and Company | $23,982 | 9 | $0 (2019) |
| ABBVIE INC. | $1,639 | 107 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $1,609 | 189 | $0 (2024) |
| Allergan, Inc. | $1,116 | 62 | $0 (2021) |
| Amgen Inc. | $952.71 | 22 | $0 (2023) |
| UPSHER-SMITH LABORATORIES LLC | $264.97 | 20 | $0 (2023) |
| Biohaven Pharmaceuticals, Inc. | $225.04 | 8 | $0 (2021) |
| Lilly USA, LLC | $206.40 | 3 | $0 (2018) |
| Lundbeck LLC | $144.49 | 9 | $0 (2024) |
| Supernus Pharmaceuticals, Inc. | $133.30 | 9 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $831.17 | 60 | ABBVIE INC. ($435.60) |
| 2023 | $1,174 | 87 | ABBVIE INC. ($611.43) |
| 2022 | $855.39 | 83 | ABBVIE INC. ($345.95) |
| 2021 | $959.26 | 72 | Biohaven Pharmaceuticals, Inc. ($225.04) |
| 2020 | $580.37 | 47 | Allergan, Inc. ($346.31) |
| 2019 | $12,188 | 61 | Eli Lilly and Company ($11,097) |
| 2018 | $9,996 | 53 | Eli Lilly and Company ($9,132) |
| 2017 | $4,680 | 37 | Eli Lilly and Company ($3,753) |
All Payment Transactions
500 individual payment records from CMS Open Payments — Page 1 of 20
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $5.97 | General |
| Category: Central Nervous System | ||||||
| 11/21/2024 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $9.56 | General |
| Category: Central Nervous System | ||||||
| 11/07/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $8.82 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/04/2024 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $9.95 | General |
| Category: Central Nervous System | ||||||
| 10/29/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $13.50 | General |
| Category: NEUROLOGY | ||||||
| 10/15/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $30.31 | General |
| Category: NEUROSCIENCE | ||||||
| 10/11/2024 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $12.16 | General |
| Category: Central Nervous System | ||||||
| 09/27/2024 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $11.00 | General |
| Category: Central Nervous System | ||||||
| 09/17/2024 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $8.79 | General |
| Category: Central Nervous System | ||||||
| 09/09/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $9.17 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 09/05/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $25.88 | General |
| Category: NEUROLOGY | ||||||
| 09/03/2024 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $11.01 | General |
| Category: Central Nervous System | ||||||
| 08/24/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $17.39 | General |
| Category: NEUROSCIENCE | ||||||
| 08/23/2024 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $8.03 | General |
| Category: Central Nervous System | ||||||
| 08/14/2024 | ABBVIE INC. | QULIPTA (Drug), BOTOX | Food and Beverage | In-kind items and services | $13.77 | General |
| Category: NEUROSCIENCE | ||||||
| 08/13/2024 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $9.45 | General |
| Category: Central Nervous System | ||||||
| 08/02/2024 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $13.35 | General |
| Category: Central Nervous System | ||||||
| 07/23/2024 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $9.58 | General |
| Category: Central Nervous System | ||||||
| 07/20/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $15.44 | General |
| Category: NEUROLOGY | ||||||
| 07/16/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $17.51 | General |
| Category: NEUROSCIENCE | ||||||
| 07/16/2024 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $12.85 | General |
| Category: Central Nervous System | ||||||
| 07/11/2024 | ABBVIE INC. | QULIPTA (Drug), BOTOX | Food and Beverage | In-kind items and services | $10.07 | General |
| Category: NEUROSCIENCE | ||||||
| 06/18/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $17.83 | General |
| Category: General - Pain Management_NMD | ||||||
| 06/18/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $13.12 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 06/14/2024 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $9.51 | General |
| Category: Central Nervous System | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF GALCANEZUMAB IN ADULTS WITH TREATMENT-RESISTANT MIGRAINE - THE CONQUER STUDY | Eli Lilly and Company | $17,741 | 4 |
| A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF LY2951742 IN PATIENTS WITH CHRONIC MIGRAINE - THE REGAIN STUDY | Eli Lilly and Company | $5,548 | 3 |
| A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF LY2951742 IN PATIENTS WITH EPISODIC MIGRAINE - THE EVOLVE-2 STUDY | Eli Lilly and Company | $542.90 | 1 |
| AN OPEN LABEL, LONG TERM, SAFETY STUDY OF LASMIDITAN 100 MG AND 200 MG IN THE ACUTE TREATMENT OF MIGRAINE GLADIATOR | Eli Lilly and Company | $150.00 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 83 | 161 | $66,210 | $10,602 |
| 2022 | 6 | 79 | 152 | $52,889 | $9,795 |
| 2021 | 5 | 82 | 207 | $80,080 | $13,443 |
| 2020 | 7 | 107 | 172 | $42,021 | $6,570 |
Total Patients
351
Total Services
692
Medicare Billing
$40,410
Procedure Codes
23
All Medicare Procedures & Services
23 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 64400 | Injection of anesthetic agent and/or steroid into face nerve | Office | 2023 | 22 | 61 | $29,975 | $4,068 | 13.6% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Office | 2023 | 12 | 32 | $16,000 | $2,615 | 16.3% |
| 64405 | Injection of anesthetic agent and/or steroid into upper neck and back of head nerve | Office | 2023 | 21 | 32 | $15,435 | $1,366 | 8.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 15 | 17 | $2,805 | $1,283 | 45.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 13 | 19 | $1,995 | $1,270 | 63.7% |
| 64400 | Injection of anesthetic agent and/or steroid into face nerve | Office | 2022 | 13 | 46 | $21,725 | $3,527 | 16.2% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Office | 2022 | 12 | 32 | $16,000 | $2,595 | 16.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 18 | 20 | $3,300 | $1,516 | 46.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 13 | 23 | $2,415 | $1,060 | 43.9% |
| 64405 | Injection of anesthetic agent and/or steroid into upper neck and back of head nerve | Office | 2022 | 11 | 19 | $9,065 | $761.78 | 8.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 12 | 12 | $384.00 | $334.89 | 87.2% |
| 64400 | Injection of anesthetic agent and/or steroid into trigeminal nerve of face | Office | 2021 | 16 | 87 | $41,800 | $6,955 | 16.6% |
| 64615 | Injection of chemical for destruction of facial and neck nerve muscles on both sides of face | Office | 2021 | 11 | 28 | $14,000 | $2,298 | 16.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 28 | 39 | $4,095 | $2,199 | 53.7% |
| 64405 | Injection of anesthetic agent and/or steroid into greater occipital nerve of upper neck and back of head | Office | 2021 | 14 | 40 | $19,600 | $1,497 | 7.6% |
| 0003A | Fee covid-19 vac 1 booster | Office | 2021 | 13 | 13 | $585.00 | $492.96 | 84.3% |
| 64400 | Injection of anesthetic agent and/or steroid into trigeminal nerve of face | Office | 2020 | 11 | 42 | $20,900 | $3,010 | 14.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 25 | 36 | $3,780 | $1,605 | 42.5% |
| 64405 | Injection of anesthetic agent and/or steroid into greater occipital nerve of upper neck and back of head | Office | 2020 | 14 | 30 | $14,455 | $1,179 | 8.2% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2020 | 11 | 14 | $1,092 | $233.50 | 21.4% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2020 | 17 | 20 | $960.00 | $209.94 | 21.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 12 | 12 | $384.00 | $194.44 | 50.6% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test | Office | 2020 | 17 | 18 | $450.00 | $138.74 | 30.8% |
About Dr. Dan Henry, MD
Dr. Dan Henry, MD is a Family Medicine healthcare provider based in Slc, Utah. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1871528018.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Dan Henry, MD has received a total of $31,265 in payments from pharmaceutical and medical device companies, with $831.17 received in 2024. These payments were reported across 500 transactions from 37 companies. The most common payment nature is "" ($23,982).
As a Medicare-enrolled provider, Henry has provided services to 351 Medicare beneficiaries, totaling 692 services with total Medicare billing of $40,410. Data is available for 4 years (2020–2023), covering 23 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Slc, UT
- Active Since 07/12/2006
- Last Updated 07/08/2007
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1871528018
Products in Payments
- UBRELVY (Drug) $1,165
- AJOVY (Biological) $1,128
- BOTOX (Biological) $563.62
- Aimovig (Biological) $488.81
- AJOVY (Drug) $457.75
- QULIPTA (Drug) $445.04
- NURTEC ODT (Drug) $264.20
- VRAYLAR (Drug) $196.11
- BOTOX (Drug) $150.71
- VYEPTI (Biological) $144.49
- TROKENDI XR (Drug) $133.30
- TOSYMRA (Drug) $130.83
- BOTOX CHRONIC MIGRAINE (Drug) $115.37
- FREESTYLE LIBRE 2 (Device) $94.27
- ZEMBRACE SYMTOUCH (Drug) $83.79
- ZTLido (Drug) $59.64
- Gralise (Drug) $59.26
- JANUVIA (Drug) $41.58
- Myrbetriq (Drug) $38.68
- BYSTOLIC (Drug) $35.25
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Slc
Nicholas Hanson, M.d, M.D
Family Medicine — Payments: $8,545
Family Medicine $8,545
Daniel Payne, Md, MD
Family Medicine — Payments: $486.01
Family Medicine $486.01
Dr. Kimberly Davis, D.o, D.O
Family Medicine — Payments: $325.46
Family Medicine $325.46
John Lawrence, Md, MD
Family Medicine
Family Medicine